EGR2 and neoplasm: Both qRT-PCR (Figures 10A, B) and Western blot (Figures 10C, D) analyses revealed significant upregulation of SLC16A3 and downregulation of EGR2 in tumor tissues compared to adjacent normal tissues, which was corroborated by immunohistochemistry (Figures 10E, F).